PPARA and metabolic dysfunction-associated steatotic liver disease: For example, gardenoside components inhibit the NAFLD-induced oxidative stress and inflammation by upregulating the Nrf2 and modulating the protein expression and AMPK/PI3K/mTOR signaling pathway [9] or improve NAFLD by upregulating PPAR-α [10].